1. Biomedicines. 2021 Jun 10;9(6):663. doi: 10.3390/biomedicines9060663.

Oncolytic Virus Immunotherapy: Showcasing Impressive Progress in Special Issue 
II.

Guo ZS(1).

Author information:
(1)UPMC Hillman Cancer Center and Departments of Surgery, Microbiology and 
Molecular Genetics, University of Pittsburgh School of Medicine, Pittsburgh, PA 
15213, USA.

Cancer immunotherapy has recently become the most promising strategy for 
hard-to-treat, advanced-stage malignancies [...].

DOI: 10.3390/biomedicines9060663
PMCID: PMC8226691
PMID: 34200560

Conflict of interest statement: The author declares no conflict of interest.